Overview
TECH market data
Price History
TECH price chart · 1M
- O
- 72.39
- H
- 72.50
- L
- 72.39
- C
- 72.47
- Vol
- 70,940.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $72.39
- Previous Close
- $72.38
- Day High
- $72.50
- Day Low
- $72.39
- 52 Week High
- $72.53
- 52 Week Low
- $43.08
- 7 Day Return
- +0.35%
- 30 Day Return
- +0.62%
- 90 Day Return
- +40.34%
- 1 Year Return
- +39.85%
- Daily Notional Volume
- $5.1M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 104.27 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.46 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.30 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.5% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 9.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $43.20 – $72.62 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $11.3B · P/B 4.20 · P/S 9.34.
Company News
Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73Benzinga · Aug 13, 2026, 9:36 PM
Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M EstimateBenzinga · Aug 12, 2026, 10:41 AM
8-K filing — BIO-TECHNE Corp (TECH)SEC EDGAR · Aug 12, 2026, 10:30 AM
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible TakeoverBenzinga · Jul 10, 2026, 1:30 PM
RBC Capital Downgrades Bio-Techne to Sector Perform, Raises Price Target to $73Benzinga · Jul 9, 2026, 3:25 PM
Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their ShareholdersGlobenewswire Inc · Jul 6, 2026, 6:15 PM
TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73Benzinga · Jun 30, 2026, 1:40 PM
Benchmark Downgrades Bio-Techne to HoldBenzinga · Jun 30, 2026, 1:20 PM
Citigroup Downgrades Bio-Techne to Neutral, Raises Price Target to $73Benzinga · Jun 29, 2026, 1:15 PM
Stephens & Co. Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73Benzinga · Jun 26, 2026, 3:30 PM